- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
- Complementary Medicine (alternative medicine) not so good for cancer patients
Monthly Archives: October 2013
I was asked this question during this weeks oncology class: Yes it does. http://en.wikipedia.org/wiki/Raloxifene http://www.cancer.gov/cancertopics/druginfo/fda-raloxifene-hydrochloride